kidney stones and glp 1 Certain diabetes drugs linked to lower risk of gout Nephroprotective effects of GLP-1 receptor

317,318 Fer-1 is a putative drug that suppresses ferroptosis, reducing oxidative damage to the hepatocyte membrane mediated by MAFLD by inhibiting hepatocyte ferroptosis

These typically improve as the body adjusts to the medication

doi: 10.1038/s41586-023-06269-0 51 RuanQWangCZhangYSunJ

[DOI] [PubMed] [Google Scholar] 140.Posokhov Y.O., Tkachenko A.S., Nakonechna O.A., Onishchenko A.I., Korniyenko Y.M., Tkachenko M.O

BPC-157 upregulates survival genes (Akt1, KRAS, Src, Foxo1), reduces inflammatory mediators (IL-6, TNF-, NOS2, NFB), scavenges reactive oxygen species through its four carboxylic groups, activates vascular bypass pathways, and maintains blood flow despite vessel occlusion